| Megan Lynn Konopka, MD | |
|
700 E Ogden Ave Ste 202, Westmont, IL 60559-1296 | |
| (630) 789-9785 | |
| Not Available |
| Full Name | Megan Lynn Konopka |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 8 Years |
| Location | 700 E Ogden Ave Ste 202, Westmont, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306295191 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 036148974 (Illinois) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 036148974 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist La Grange Memorial Hospital | La grange, IL | Hospital |
| Adventist Hinsdale Hospital | Hinsdale, IL | Hospital |
| Adventist Bolingbrook Hospital | Bolingbrook, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Suburban Pulmonary And Sleep Associates Ltd | 3476531088 | 23 |
News Archive
New research published in the March 2016 issue of The FASEB Journal, shows that a commonly prescribed class of high blood pressure drugs may have the potential to slow the growth of triple negative breast cancer tumors. These drugs, called "beta blockers" work by counteracting the pro-growth effect caused by adrenaline by affecting the the beta2-adrenoceptor.
Potential new treatments for Parkinson's disease developed by researchers at Rush University Medical Center have shown success in slowing progression of the disease in mice.
Treatment for individuals who experience psychosis, such as hallucinations and delusions as a result of a psychiatric illness, can be targeted to a specific structural mutation, according to a study published by researchers from McLean Hospital and other institutions in the journal Biological Psychiatry.
Using a novel noninvasive technique, a team of researchers led by a professor at the University of Texas Arlington's College of Nursing and Health Innovation has been able to measure oxygen consumption in the legs of heart failure patients, providing additional insight into this syndrome.
› Verified 6 days ago
| Entity Name | Suburban Pulmonary & Sleep Associates Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649283896 PECOS PAC ID: 3476531088 Enrollment ID: O20040709001417 |
News Archive
New research published in the March 2016 issue of The FASEB Journal, shows that a commonly prescribed class of high blood pressure drugs may have the potential to slow the growth of triple negative breast cancer tumors. These drugs, called "beta blockers" work by counteracting the pro-growth effect caused by adrenaline by affecting the the beta2-adrenoceptor.
Potential new treatments for Parkinson's disease developed by researchers at Rush University Medical Center have shown success in slowing progression of the disease in mice.
Treatment for individuals who experience psychosis, such as hallucinations and delusions as a result of a psychiatric illness, can be targeted to a specific structural mutation, according to a study published by researchers from McLean Hospital and other institutions in the journal Biological Psychiatry.
Using a novel noninvasive technique, a team of researchers led by a professor at the University of Texas Arlington's College of Nursing and Health Innovation has been able to measure oxygen consumption in the legs of heart failure patients, providing additional insight into this syndrome.
› Verified 6 days ago
| Entity Name | Rush Oak Park Nocturnist |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518260165 PECOS PAC ID: 6406032887 Enrollment ID: O20110519000475 |
News Archive
New research published in the March 2016 issue of The FASEB Journal, shows that a commonly prescribed class of high blood pressure drugs may have the potential to slow the growth of triple negative breast cancer tumors. These drugs, called "beta blockers" work by counteracting the pro-growth effect caused by adrenaline by affecting the the beta2-adrenoceptor.
Potential new treatments for Parkinson's disease developed by researchers at Rush University Medical Center have shown success in slowing progression of the disease in mice.
Treatment for individuals who experience psychosis, such as hallucinations and delusions as a result of a psychiatric illness, can be targeted to a specific structural mutation, according to a study published by researchers from McLean Hospital and other institutions in the journal Biological Psychiatry.
Using a novel noninvasive technique, a team of researchers led by a professor at the University of Texas Arlington's College of Nursing and Health Innovation has been able to measure oxygen consumption in the legs of heart failure patients, providing additional insight into this syndrome.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Megan Lynn Konopka, MD 700 E Ogden Ave Ste 202, Westmont, IL 60559-1296 Ph: (630) 789-9785 | Megan Lynn Konopka, MD 700 E Ogden Ave Ste 202, Westmont, IL 60559-1296 Ph: (630) 789-9785 |
News Archive
New research published in the March 2016 issue of The FASEB Journal, shows that a commonly prescribed class of high blood pressure drugs may have the potential to slow the growth of triple negative breast cancer tumors. These drugs, called "beta blockers" work by counteracting the pro-growth effect caused by adrenaline by affecting the the beta2-adrenoceptor.
Potential new treatments for Parkinson's disease developed by researchers at Rush University Medical Center have shown success in slowing progression of the disease in mice.
Treatment for individuals who experience psychosis, such as hallucinations and delusions as a result of a psychiatric illness, can be targeted to a specific structural mutation, according to a study published by researchers from McLean Hospital and other institutions in the journal Biological Psychiatry.
Using a novel noninvasive technique, a team of researchers led by a professor at the University of Texas Arlington's College of Nursing and Health Innovation has been able to measure oxygen consumption in the legs of heart failure patients, providing additional insight into this syndrome.
› Verified 6 days ago
Laisvyde Smajkic, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 801 N Cass Ave, Ste 150, Westmont, IL 60559 Phone: 630-268-0200 | |
Dr. Vasantha Samala, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 700 E Ogden Ave, Suite 202, Westmont, IL 60559 Phone: 630-789-9785 Fax: 630-789-9798 | |
Dr. Brandon William Segrest, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 700 E Ogden Ave Ste 202, Westmont, IL 60559 Phone: 630-528-3215 Fax: 630-528-3219 | |
Andrew Yu, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 303 W Ogden Ave Ste D12, Westmont, IL 60559 Phone: 630-871-6699 | |
Erum Arain, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 700 E Ogden Ave Ste 202, Westmont, IL 60559 Phone: 630-789-9785 | |
Dr. Arnon E Rubin, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 700 E Ogden Ave, Ste 202, Westmont, IL 60559 Phone: 630-789-9785 Fax: 630-789-9798 | |
Melwin Joseph, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 700 E Ogden Ave Ste 202, Westmont, IL 60559 Phone: 630-528-3215 Fax: 630-528-3219 |